Artykuły w czasopismach na temat „Dopaminergic neurons - Transplantation”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Dopaminergic neurons - Transplantation”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Breeze, Robert E. "TRANSPLANTATION OF EMBRYONIC DOPAMINERGIC NEURONS". Neurosurgery 49, nr 3 (1.09.2001): 575–76. http://dx.doi.org/10.1097/00006123-200109000-00006.
Pełny tekst źródłaBreeze, Robert E. "TRANSPLANTATION OF EMBRYONIC DOPAMINERGIC NEURONS". Neurosurgery 49, nr 3 (wrzesień 2001): 575–76. http://dx.doi.org/10.1227/00006123-200109000-00006.
Pełny tekst źródłaLindvall, Olle. "Treatment of Parkinson's disease using cell transplantation". Philosophical Transactions of the Royal Society B: Biological Sciences 370, nr 1680 (19.10.2015): 20140370. http://dx.doi.org/10.1098/rstb.2014.0370.
Pełny tekst źródłaXiao, Jia-Jia, Ming Yin, Ze-Jian Wang i Xiao-Ping Wang. "Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?" Oxidative Medicine and Cellular Longevity 2015 (2015): 1–9. http://dx.doi.org/10.1155/2015/618631.
Pełny tekst źródłaLi, Wen, Elisabet Englund, Håkan Widner, Bengt Mattsson, Danielle van Westen, Jimmy Lätt, Stig Rehncrona i in. "Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain". Proceedings of the National Academy of Sciences 113, nr 23 (2.05.2016): 6544–49. http://dx.doi.org/10.1073/pnas.1605245113.
Pełny tekst źródłaPetersén, Åsa, Oskar Hansson, Mia Emgård i Patrik Brundin. "Grafting of Nigral Tissue Hibernated with Tirilazad Mesylate and Glial Cell Line-Derived Neurotrophic Factor". Cell Transplantation 9, nr 5 (wrzesień 2000): 577–84. http://dx.doi.org/10.1177/096368970000900503.
Pełny tekst źródłaSawamoto, K., N. Nakao, K. Kobayashi, N. Matsushita, H. Takahashi, K. Kakishita, A. Yamamoto i in. "Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons". Proceedings of the National Academy of Sciences 98, nr 11 (15.05.2001): 6423–28. http://dx.doi.org/10.1073/pnas.111152398.
Pełny tekst źródłaVukicevic, Vladimir, Janine Schmid, Andreas Hermann, Sven Lange, Nan Qin, Linda Gebauer, Kuei-Fang Chung i in. "Differentiation of Chromaffin Progenitor Cells to Dopaminergic Neurons". Cell Transplantation 21, nr 11 (listopad 2012): 2471–86. http://dx.doi.org/10.3727/096368912x638874.
Pełny tekst źródłaPark, Hyunjun, i Keun-A. Chang. "Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model". International Journal of Molecular Sciences 21, nr 21 (30.10.2020): 8129. http://dx.doi.org/10.3390/ijms21218129.
Pełny tekst źródłaEmgard-Mattson, Mia, Jenny Karlsson, Naoyuki Nakao i Patrik Brundin. "Addition of Lateral Ganglionic Eminence to Rat Mesencephalic Grafts Affects Fiber Outgrowth but Does not Enhance Function". Cell Transplantation 6, nr 3 (maj 1997): 277–86. http://dx.doi.org/10.1177/096368979700600310.
Pełny tekst źródłaOkano, Hideyuki, Takahito Yoshizaki, Takuya Shimazaki i Kazunobu Sawamoto. "Isolation and transplantation of dopaminergic neurons and neural stem cells". Parkinsonism & Related Disorders 9, nr 1 (październik 2002): 23–28. http://dx.doi.org/10.1016/s1353-8020(02)00041-x.
Pełny tekst źródłaLiu, Qiuyue, Oliver Z. Pedersen, Jun Peng, Larry A. Couture, Mahendra S. Rao i Xianmin Zeng. "Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation". Cytotherapy 15, nr 8 (sierpień 2013): 999–1010. http://dx.doi.org/10.1016/j.jcyt.2013.03.006.
Pełny tekst źródłaKarlsson, Jenny, ÅSa Petersén, Gunilla Gidö, Tadeusz Wieloch i Patrik Brundin. "Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient". Cell Transplantation 14, nr 5 (maj 2005): 301–9. http://dx.doi.org/10.3727/000000005783983089.
Pełny tekst źródłaThompson, Cassandra, Paulina Otero, Bhairavi Srinageshwar, Robert B. Petersen, Gary L. Dunbar i Julien Rossignol. "Possible roles of epigenetics in stem cell therapy for Parkinson’s disease". Epigenomics 12, nr 7 (kwiecień 2020): 647–56. http://dx.doi.org/10.2217/epi-2019-0347.
Pełny tekst źródłaLindvall, Olle, i Peter Hagell. "Role of cell therapy in Parkinson disease". Neurosurgical Focus 13, nr 5 (listopad 2002): 1–9. http://dx.doi.org/10.3171/foc.2002.13.5.3.
Pełny tekst źródłaYasuhara, Takao, Tetsuro Shingo, Kenichiro Muraoka, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Yuan WenJi i in. "Early transplantation of an encapsulated glial cell line—derived neurotrophic factor—producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease". Journal of Neurosurgery 102, nr 1 (styczeń 2005): 80–89. http://dx.doi.org/10.3171/jns.2005.102.1.0080.
Pełny tekst źródłaGalpern, Wendy R., David M. Frim, Stephen B. Tatter, C. Anthony Altar, M. Flint Beal i Ole Isacson. "Cell-Mediated Delivery of Brain-Derived Neurotrophic Factor Enhances Dopamine Levels in an Mpp+ Rat Model of Substantia Nigra Degeneration". Cell Transplantation 5, nr 2 (marzec 1996): 225–32. http://dx.doi.org/10.1177/096368979600500211.
Pełny tekst źródłaHebb, Adam O., Kari Hebb, Arun C. Ramachandran i Ivar Mendez. "Glial cell line–derived neurotrophic factor–supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage". Neurosurgical Focus 13, nr 5 (listopad 2002): 1–6. http://dx.doi.org/10.3171/foc.2002.13.5.5.
Pełny tekst źródłaKhanna, Aparna, Anna Maria Swistowska, Mahendra Rao i Xianmin Zeng. "Generation and Transplantation of Dopaminergic Neurons Derived from Embryonic Stem Cells". Current Stem Cell Research & Therapy 2, nr 2 (1.05.2007): 139–47. http://dx.doi.org/10.2174/157488807780599266.
Pełny tekst źródłaFerrazoli, Enéas G., Héllio D. N. De Souza, Isis C. Nascimento, Ágatha Oliveira-Giacomelli, Telma T. Schwindt, Luiz R. Britto i Henning Ulrich. "Brilliant Blue G, but not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease". Cell Transplantation 26, nr 4 (kwiecień 2017): 669–77. http://dx.doi.org/10.3727/096368917x695227.
Pełny tekst źródłaHebb, Adam O., Kari Hebb, Arun C. Ramachandran i Ivar Mendez. "Glial cell line—derived neurotrophic factor—supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage". Journal of Neurosurgery 98, nr 5 (maj 2003): 1078–83. http://dx.doi.org/10.3171/jns.2003.98.5.1078.
Pełny tekst źródłaWeiss, B., S. Haas, G. Lessner, S. Mikkat, M. Kreutzer, M. O. Glocker, A. Wree i O. Schmitt. "The Proteome of the Differentiating Mesencephalic Progenitor Cell Line CSM14.1In Vitro". BioMed Research International 2014 (2014): 1–13. http://dx.doi.org/10.1155/2014/351821.
Pełny tekst źródłaChi, Heng, Yunqian Guan, Fengyan Li i Zhiguo Chen. "The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson’s Disease Model". Cell Transplantation 28, nr 1_suppl (28.11.2019): 87S—99S. http://dx.doi.org/10.1177/0963689719891134.
Pełny tekst źródłaVidal, Nina, Lars Björklund i Ingrid Strömberg. "Morphological and Functional Evidence for Enhanced Growth and Potassium-Evoked Dopamine Release in Striatal Grafts Innervated with a Patchy Growth Pattern. an in Oculo Nigrostriatal Cograft Study". Cell Transplantation 7, nr 2 (marzec 1998): 97–108. http://dx.doi.org/10.1177/096368979800700205.
Pełny tekst źródłaDi Santo, Stefano, Stefanie Seiler, Angélique D. Ducray, Morten Meyer i Hans Rudolf Widmer. "A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures but not after Intrastriatal Transplantation in a Rat Model of Parkinson's Disease". Cell Transplantation 26, nr 4 (kwiecień 2017): 679–91. http://dx.doi.org/10.3727/096368916x693707.
Pełny tekst źródłaCameron, D. F., A. I. Othberg, C. V. Borlongan, S. Rashed, A. Anton, S. Saporta i P. R. Sanberg. "Post-Thaw Viability and Functionality of Cryopreserved Rat Fetal Brain Cells Cocultured with Sertoli Cells". Cell Transplantation 6, nr 2 (marzec 1997): 185–89. http://dx.doi.org/10.1177/096368979700600212.
Pełny tekst źródłaYoshizaki, Takahito, Motoki Inaji, Hiroko Kouike, Takuya Shimazaki, Kazunobu Sawamoto, Kiyoshi Ando, Isao Date i in. "Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells". Neuroscience Letters 363, nr 1 (czerwiec 2004): 33–37. http://dx.doi.org/10.1016/j.neulet.2004.03.074.
Pełny tekst źródłaFrancis, Nicola L., Nanxia Zhao, Hannah R. Calvelli, Astha Saini, Janace J. Gifford, George C. Wagner, Rick I. Cohen, Zhiping P. Pang i Prabhas V. Moghe. "Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons". Tissue Engineering Part A 26, nr 3-4 (1.02.2020): 193–205. http://dx.doi.org/10.1089/ten.tea.2019.0094.
Pełny tekst źródłaBrundin, Patrik, Jenny Karlsson, Mia Emgård, Gabriele S. Kaminski Schierle, Oskar Hansson, Åsa Petersén i Roger F. Castilho. "Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches". Cell Transplantation 9, nr 2 (marzec 2000): 179–95. http://dx.doi.org/10.1177/096368970000900205.
Pełny tekst źródłaAndres, Robert H., Angelique D. Ducray, Alberto Pérez-Bouza, Uwe Schlattner, Alexander W. Huber, Sandra H. Krebs, Rolf W. Seiler, Theo Wallimann i Hans R. Widmer. "Creatine Supplementation Improves Dopaminergic Cell Survival and Protects against MPP+ Toxicity in an Organotypic Tissue Culture System". Cell Transplantation 14, nr 8 (wrzesień 2005): 537–50. http://dx.doi.org/10.3727/000000005783982756.
Pełny tekst źródłaTsai, Chia-Wen, Rong-Tzong Tsai, Shih-Ping Liu, Chang-Shi Chen, Min-Chen Tsai, Shao-Hsuan Chien, Huey-Shan Hung, Shinn-Zong Lin, Woei-Cherng Shyu i Ru-Huei Fu. "Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson’s Disease". Cell Transplantation 26, nr 12 (grudzień 2017): 1903–18. http://dx.doi.org/10.1177/0963689717738785.
Pełny tekst źródłaCollier, Timothy J., D. Eugene Redmond, Robert H. Roth, John D. Elsworth, Jane R. Taylor i John R. Sladek. "Metabolic Energy Capacity of Dopaminergic Grafts and the Implanted Striatum in Parkinsonian Nonhuman Primates as Visualized with Cytochrome Oxidase Histochemistry". Cell Transplantation 6, nr 2 (marzec 1997): 135–40. http://dx.doi.org/10.1177/096368979700600207.
Pełny tekst źródłaStromberg, Ingrid, Lars Björklund i Petter Forander. "The Age of Striatum Determines the Pattern and Extent of Dopaminergic Innervation: a Nigrostriatal Double Graft Study". Cell Transplantation 6, nr 3 (maj 1997): 287–96. http://dx.doi.org/10.1177/096368979700600311.
Pełny tekst źródłaBartlett, L. E., i I. Mendez. "Dopaminergic Reinnervation of the Globus Pallidus by Fetal Nigral Grafts in the Rodent Model of Parkinson's Disease". Cell Transplantation 14, nr 2-3 (luty 2005): 119–27. http://dx.doi.org/10.3727/000000005783983241.
Pełny tekst źródłaSaporta, Samuel, Cesario Borlongan, Joann Moore, Elizabeth Mejia-Millan, Stacey L. Jones, Patrice Bonness, Timothy S. Randall, Richard C. Allen, Thomas B. Freeman i Paul R. Sanberg. "Microcarrier Enhanced Survival of Human and Rat Fetal Ventral Mesencephalon Cells Implanted in the Rat Striatum". Cell Transplantation 6, nr 6 (listopad 1997): 579–84. http://dx.doi.org/10.1177/096368979700600608.
Pełny tekst źródłaDeacon, Terrence, Jonathan Dinsmore, Lauren C. Costantini, Judson Ratliff i Ole Isacson. "Blastula-Stage Stem Cells Can Differentiate into Dopaminergic and Serotonergic Neurons after Transplantation". Experimental Neurology 149, nr 1 (styczeń 1998): 28–41. http://dx.doi.org/10.1006/exnr.1997.6674.
Pełny tekst źródłaJhao, Yun-Ting, Chuang-Hsin Chiu, Chien-Fu F. Chen, Ta-Kai Chou, Yi-Wen Lin, Yu-Ten Ju, Shinn-Chih Wu i in. "The Effect of Sertoli Cells on Xenotransplantation and Allotransplantation of Ventral Mesencephalic Tissue in a Rat Model of Parkinson’s Disease". Cells 8, nr 11 (11.11.2019): 1420. http://dx.doi.org/10.3390/cells8111420.
Pełny tekst źródłaMousavinejad, M., S. Skidmore, F. G. Barone, P. Tyers, V. Pisupati, H. Poptani, A. Plagge i in. "Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging Techniques". Molecular Imaging and Biology 22, nr 5 (6.05.2020): 1244–54. http://dx.doi.org/10.1007/s11307-020-01499-4.
Pełny tekst źródłaOthberg, Agneta I., Alison E. Willing, Don F. Cameron, Alex Anton, Samuel Saporta, Thomas B. Freeman i Paul R. Sanberg. "Trophic Effect of Porcine Sertoli Cells on Rat and Human Ventral Mesencephalic Cells and Hnt Neurons in Vitro". Cell Transplantation 7, nr 2 (marzec 1998): 157–64. http://dx.doi.org/10.1177/096368979800700210.
Pełny tekst źródłaMcgrath, John, Elishia Lintz, Barry J. Hoffer, Greg A. Gerhardt, E. Matthew Quintero i Ann-Charlotte Granholm. "Adeno-Associated Viral Delivery of GDNF Promotes Recovery of Dopaminergic Phenotype following a Unilateral 6-Hydroxydopamine Lesion". Cell Transplantation 11, nr 3 (kwiecień 2002): 215–27. http://dx.doi.org/10.3727/096020198389988.
Pełny tekst źródłaLove, R. M., R. L. Branton, J. Karlsson, P. Brundin i D. J. Clarke. "Effects of Antioxidant Pretreatment on the Survival of Embryonic Dopaminergic Neurons In Vitro and following Grafting in an Animal Model of Parkinson's Disease". Cell Transplantation 11, nr 7 (październik 2002): 653–62. http://dx.doi.org/10.3727/000000002783985431.
Pełny tekst źródłaMehta, Vivek, Murray Hong, Julian Spears i Ivar Mendez. "Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor". Neurosurgical Focus 7, nr 3 (wrzesień 1999): E6. http://dx.doi.org/10.3171/foc.1999.7.3.7.
Pełny tekst źródłaChi, Kang, Ru-Huei Fu, Yu-Chuen Huang, Shih-Yin Chen, Ching-Ju Hsu, Shinn-Zong Lin, Chi-Tang Tu, Li-Hsun Chang, Ping-An Wu i Shih-Ping Liu. "Adipose-derived Stem Cells Stimulated with n-Butylidenephthalide Exhibit Therapeutic Effects in a Mouse Model of Parkinson’s Disease". Cell Transplantation 27, nr 3 (marzec 2018): 456–70. http://dx.doi.org/10.1177/0963689718757408.
Pełny tekst źródłaAdil, Maroof M., Tandis Vazin, Badriprasad Ananthanarayanan, Gonçalo M. C. Rodrigues, Antara T. Rao, Rishikesh U. Kulkarni, Evan W. Miller, Sanjay Kumar i David V. Schaffer. "Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons". Biomaterials 136 (sierpień 2017): 1–11. http://dx.doi.org/10.1016/j.biomaterials.2017.05.008.
Pełny tekst źródłaArendash, Gary W., i Peter C. K. Leung. "Alleviation of Estrogen-Induced Hyperprolactinemia through Intracerebral Transplantation of Hypothalamic Tissue Containing Dopaminergic Neurons". Neuroendocrinology 43, nr 3 (1986): 359–67. http://dx.doi.org/10.1159/000124551.
Pełny tekst źródłaHoban, Deirdre B., Shelby Shrigley, Bengt Mattsson, Ludivine S. Breger, Ulla Jarl, Tiago Cardoso, Jenny Nelander Wahlestedt, Kelvin C. Luk, Anders Björklund i Malin Parmar. "Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD". Proceedings of the National Academy of Sciences 117, nr 26 (15.06.2020): 15209–20. http://dx.doi.org/10.1073/pnas.2001305117.
Pełny tekst źródłaBallagi, Andrea E., Per Odin, Agneta Othberg-Cederström, Anja Smits, Wei-Ming Duandr, Olle Lindvall i Keiko Funa. "Platelet-Derived Growth Factor Receptor Expression after Neural Grafting in a Rat Model of Parkinson's Disease". Cell Transplantation 3, nr 6 (listopad 1994): 453–60. http://dx.doi.org/10.1177/096368979400300602.
Pełny tekst źródłaBehl, Tapan, Ishnoor Kaur, Arun Kumar, Vineet Mehta, Gokhan Zengin i Sandeep Arora. "Gene Therapy in the Management of Parkinson’s Disease: Potential of GDNF as a Promising Therapeutic Strategy". Current Gene Therapy 20, nr 3 (9.10.2020): 207–22. http://dx.doi.org/10.2174/1566523220999200817164051.
Pełny tekst źródłaMehta, Vivek, Murray Hong, Julian Spears i Ivar Mendez. "Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line—derived neurotrophic factor". Journal of Neurosurgery 88, nr 6 (czerwiec 1998): 1088–95. http://dx.doi.org/10.3171/jns.1998.88.6.1088.
Pełny tekst źródłaGranholm, Ann-Charlotte, Stephanie Henry, Meleik A. Hebert, Servet Eken, Greg A. Gerhardt i Craig Van Horne. "Kidney Cografts Enhance Fiber Outgrowth from Ventral Mesencephalic Grafts to the 6-Ohda–Lesioned Striatum, and Improve Behavioral Recovery". Cell Transplantation 7, nr 2 (marzec 1998): 197–212. http://dx.doi.org/10.1177/096368979800700214.
Pełny tekst źródła